NonExomics
The AI engine Fit Assessment
BetaNonExomics leverages machine learning to discover new patterns in genomic data and expand therapeutics for rare diseases.
Blurb
NonExomics develops therapeutics to diagnose and cure diseases emanating from the nonexome.
HQ Location
Acton (United States)
Founded
2021
Employees
1 - 10
Total funding raised
$200.00K
Last Funding Event
Non-Equity Assistance, March 16, 2022
Smart insights
- Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
- Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
- 6m headcount growth: 25%
- 1Y headcount growth: 94%
- Headcount-to-last-round ratio: 5.3 employees/$M
Subspaces
- Genomic Data Analysis
NonExomics integrates genomics, transcriptomic, and proteomics data by utilizing proprietary machine learning approaches to predict structures of nonexomic proteins and identifies disease-specific nonexomic targets, allowing clients to find cures for rare diseases.